(Q33714290)

28 July 2017

1 reference

title

Premenstrual syndrome, neuroactive steroids and the brain (English)

1 reference

28 July 2017

main subject

premenstrual syndrome

1 reference

6

Bixo M

1 reference

28 July 2017

Torbjörn C. Bäckström

2

object named as

Bäckström T

1 reference

28 July 2017

Sundström I

1

1 reference

28 July 2017

Wang M

3

1 reference

28 July 2017

Olsson T

4

1 reference

28 July 2017

Seippel L

5

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Gynecological Endocrinology

28 July 2017

published in

1 reference

28 July 2017

volume

13

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

206-220

1 reference

Influence of premenstrual syndrome on family, social life, and work performance

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Premenstrual depression predicts future major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Longitudinal sleep EEG, temperature, and activity measurements across the menstrual cycle in patients with premenstrual depression and in age-matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Late luteal phase dysphoric disorder: a scientific puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

The menstrual cycle and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Psychiatric Emergency Related to the Menstrual Cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Suicide attempts in hypo-oestrogenic phases of the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Lactate provocation of panic attacks. I. Clinical and behavioral findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Panic disorder. Pathophysiology and drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

The influence of premenstrual syndrome on ratings of anxiety in women with generalized anxiety disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Menstrual fluctuation in the symptoms of panic anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Anxiety and the menstrual cycle in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Effect of pregnancy on panic attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Relationship between symptom severity and hormone changes in women with premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Double-blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Lack of effect of induced menses on symptoms in women with premenstrual syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Estrogen effects on cognition in menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

The anaesthetic potency of 3 alpha-hydroxy-5 alpha-pregnan-20-one and 3 alpha-hydroxy-5 beta-pregnan-20-one determined with an intravenous EEG-threshold method in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

The EEG burst suppression threshold test for the determination of CNS sensitivity to intravenous anesthetics in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Neurosteroids act on recombinant human GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Differential responses of expressed recombinant human gamma-aminobutyric acidA receptors to neurosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

5 alpha-reductase activity in isolated and cultured neuronal and glial cells of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Expression of steroid metabolizing enzymes by aggregating fetal brain cells in culture: a model for developmental regulation of the progesterone 5 alpha-reductase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Progesterone, 5alpha-pregnane-3,20-dione and 3alpha-hydroxy-5alpha-pregnane-20-one in specific regions of the human female brain in different endocrine states

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABAA Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

The effect of progesterone and its metabolites on the interictal epileptiform discharge in the cat's cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

The neurosteroid, 3 alpha-hydroxy-5 alpha-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Anxiolytic metabolites of progesterone: correlation with mood and performance measures following oral progesterone administration to healthy female volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Influence of route of administration on progesterone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Anxiolytic effects of progesterone are sexually dimorphic

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Arousal and stress response across the menstrual cycle in women with three perimenstrual symptom patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

State-dependent alterations in the perception of life events in menstrual-related mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Psychosocial factors in premenstrual dysphoria: stressors, appraisal, and coping processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Repeated swim-stress reduces GABAA receptor α subunit mRNAs in the mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Acute tryptophan depletion aggravates premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Altered serotonergic activity in women with dysphoric premenstrual syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Tryptophan and neutral amino acids in premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Thrombocyte monoamine oxidase activity and personality traits in women with severe premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Effects of steroid hormones on the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Changes in Hypothalamic Serotonin Associated with Amplification of LH Surges by Progesterone in Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Serotonin metabolite excretion after postmenopausal estradiol therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Chronic GnRH agonist administration down-regulates platelet serotonin transporter in women undergoing assisted reproductive treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Effects of antidepressant treatment on neuroactive steroids in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Lactate infusion induces panic attacks in patients with premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Benzodiazepine sensitivity in normal human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Reduced benzodiazepine sensitivity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Merck, Sharp & Dohme Prize for Young Psychopharmacologists: The pharmacology of saccadic eye movements

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Chronic neurosteroid treatment attenuates single cell GABAA response and its potentiation by modulators in cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Progesterone withdrawal decreases latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Late luteal phase dysphoric disorder in 670 women evaluated for premenstrual complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Colocalization of progestin receptors with serotonin in raphe neurons of macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Colocalization of Oestrogen Receptor lmmunoreactivity and Preproenkephalin mRNA Expression to Neurons in the Superficial Laminae of the Spinal and Medullary Dorsal Horn of Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

Cyclical mood changes as in the Premenstrual tension Syndrome during Sequential Estrogen-Progestagen Postmenopausal Replacement Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513599909167557

10.3109/09513599909167557

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference